RxDoctor Payments Data

Ryan O'Hara, MD

Vascular & Interventional Radiology · Murray, UTNPI 1821154121

Payments from drug & device makers

What this record shows

This record is dominated by other: $105,500 of the $154,222 with a category attached, or 68.4%. Angiodynamics, Inc. accounts for 75.1% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2022 at $33,251 and has fallen 53.4% since, to $15,500 in 2025. Among vascular & interventional radiology clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$154,222in general payments, 2019–2025

Across 123 payments — averaging $1253.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Angiodynamics, Inc.$116K
  • Sirtex Medical Inc$33K
  • Nevro Corp.$2K
  • Siemens Medical Solutions USA, Inc.$930
  • Merit Medical Systems Inc$869
  • Stryker$634
  • plus $1K from 11 others

What the payments were for

  • Consulting fees$1,7501%
  • Speaking & faculty fees$28,89219%
  • Travel & lodging$5,6744%
  • Food & beverage$2,5732%
  • Education$9,8336%
  • Other$105,50068%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$154,222 in reported general payments places this provider in the 95th percentile of 38 vascular & interventional radiology providers in Utah.

See all vascular & interventional radiology providers in Utah

Medicare billing

Part B allowed, 2024
$757,813
Medicare patients
489
Services billed
1,631

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban41$38,335
Pregabalin11$376
Gabapentin43$348
ClopidogrelClopidogrel Bisulfate18$209
Atorvastatin Calcium27$186
Methylprednisolone14$133
Ciprofloxacin Hcl13$47
Ibuprofen11$34

Paid to pharmacies, not to this prescriber.

Other vascular & interventional radiology in Murray

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →